Biología molecular del cáncer
University of South Carolina
Columbia, Estados UnidosUniversity of South Carolina-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1